Clinical Trials
5 trialsNCT03228667 2026-01-14
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
ImmunityBio, Inc.
Phase 2 Active not recruiting
NCT01256359 2024-08-15
DOC-MEK
University of Oxford
Phase 2 Completed
NCT00256282 2018-05-03
Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma
University of California, Irvine
Phase 2 Completed
NCT01009775 2015-09-04
A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma
Astellas Pharma Inc
Phase 2 Completed
NCT02223884 2014-08-29
A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy
Yonsei University
Phase 2 Completed